P Li1, H Fan1, Q He2. 1. Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital Affiliated to Capital Medical University, 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China. 2. Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital Affiliated to Capital Medical University, 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, 100020, China. heqiang349@sina.com.
Abstract
BACKGROUND: It has been demonstrated that the prognosis of liver transplantation (LT) is significantly influenced by pretransplant factors, such as diabetes mellitus (DM). However, inconsistent observations are obtained. METHODS: We comprehensively searched PubMed, Embase and Web of Science to identify eligible cohort studies to evaluate the impact of preexisting DM on LT prognosis. Overall mortality and graft loss, as the most frequently observed parameters, were used to evaluate the outcomes of LT. Hazard ratios (HRs) with their 95% confidence intervals (CIs) were pooled to assess the effect of DM. RESULTS: 15,768 diabetic LT recipients and 60,176 non-diabetic LT recipients from 13 populations were included in this meta-analysis. Preexisting DM increased the risk for overall death of LT by 40% (95% CI 1.22-1.61), compared with DM-free patients. In addition, the risk for graft loss was also elevated by pretransplant DM (HR 1.28, 95% CI 1.07-1.54). Both analyses showed high heterogeneities (I 2 = 85.2 and 93.2%, respectively) and their sources were not identified by meta-regression analyses. In terms of the additive effect of hepatitis C virus (HCV) infection on poor outcomes of diabetic LT recipients, stratified meta-analyses were conducted. It was demonstrated that HCV infection increased the risk for mortality by 73% (95% CI 1.64-1.83), relatively higher than non-HCV recipients (HR 1.32, 95% CI 1.25-1.39) and general population (HR 1.40, 95% CI 1.22-1.61). CONCLUSION: Preexisting DM predicts worse patient and graft survivals of LT. Concomitant HCV infection would further deteriorate this unfavorable impact. Given the high heterogeneities and the insufficient evidences, more studies are still warranted to support these observations.
BACKGROUND: It has been demonstrated that the prognosis of liver transplantation (LT) is significantly influenced by pretransplant factors, such as diabetes mellitus (DM). However, inconsistent observations are obtained. METHODS: We comprehensively searched PubMed, Embase and Web of Science to identify eligible cohort studies to evaluate the impact of preexisting DM on LT prognosis. Overall mortality and graft loss, as the most frequently observed parameters, were used to evaluate the outcomes of LT. Hazard ratios (HRs) with their 95% confidence intervals (CIs) were pooled to assess the effect of DM. RESULTS: 15,768 diabetic LT recipients and 60,176 non-diabetic LT recipients from 13 populations were included in this meta-analysis. Preexisting DM increased the risk for overall death of LT by 40% (95% CI 1.22-1.61), compared with DM-free patients. In addition, the risk for graft loss was also elevated by pretransplant DM (HR 1.28, 95% CI 1.07-1.54). Both analyses showed high heterogeneities (I 2 = 85.2 and 93.2%, respectively) and their sources were not identified by meta-regression analyses. In terms of the additive effect of hepatitis C virus (HCV) infection on poor outcomes of diabetic LT recipients, stratified meta-analyses were conducted. It was demonstrated that HCV infection increased the risk for mortality by 73% (95% CI 1.64-1.83), relatively higher than non-HCV recipients (HR 1.32, 95% CI 1.25-1.39) and general population (HR 1.40, 95% CI 1.22-1.61). CONCLUSION: Preexisting DM predicts worse patient and graft survivals of LT. Concomitant HCV infection would further deteriorate this unfavorable impact. Given the high heterogeneities and the insufficient evidences, more studies are still warranted to support these observations.
Authors: A Sidney Barritt; Evan S Dellon; Tomasz Kozlowski; David A Gerber; Paul H Hayashi Journal: J Clin Gastroenterol Date: 2011-04 Impact factor: 3.062
Authors: Anna J Dare; Lindsay D Plank; Anthony R J Phillips; Edward J Gane; Barry Harrison; David Orr; Yannan Jiang; Adam S J R Bartlett Journal: Liver Transpl Date: 2014-03 Impact factor: 5.799
Authors: Anton I Skaro; Lorenzo G Gallon; Vadim Lyuksemburg; Colleen L Jay; Lihui Zhao; Daniela P Ladner; Lisa B VanWagner; Andre M De Wolf; James D Flaherty; Josh Levitsky; Michael M Abecassis; Mihai Gheorghiade Journal: J Cardiovasc Med (Hagerstown) Date: 2016-12 Impact factor: 2.160
Authors: Martin F Sprinzl; Arndt Weinmann; Nikola Lohse; Hanna Tönissen; Sandra Koch; Jörn Schattenberg; Maria Hoppe-Lotichius; Tim Zimmermann; Peter R Galle; Torsten Hansen; Gerd Otto; Marcus Schuchmann Journal: Transpl Int Date: 2012-11-05 Impact factor: 3.782
Authors: Leon A Adams; Oscar Arauz; Peter W Angus; Marie Sinclair; Graeme A MacDonald; Utti Chelvaratnam; Alan J Wigg; Sze Yeap; Nicholas Shackel; Linda Lin; Spiro Raftopoulos; Geoffrey W McCaughan; Gary P Jeffrey Journal: J Gastroenterol Hepatol Date: 2016-05 Impact factor: 4.029
Authors: Chutwichai Tovikkai; Susan C Charman; Raaj K Praseedom; Alexander E Gimson; Jan van der Meulen Journal: BMJ Open Date: 2015-05-14 Impact factor: 2.692